Our Solution Finder can find DuPont brands and products to help your company solve its challenges.

Jun 1, 2019 · DuPont Investors. Filings & Reports; Events & Presentations; Stock & Dividend Information. Nutrition & Biosciences, Inc. Tax Related Information; Corporate Governance. DuPont Leadership; DuPont Board; Contact the Board of Directors; Contact Investor Relations; Email Alerts; FAQ; DuPont Investors - Prior to June 1, 2019. Filings & Reports ...

Built on a heritage of scientific innovation and driven by collaborative spirit, DuPont attracts the kind of people whose passions go beyond research and development. They want to change lives.

Feb 11, 2025 · "DuPont closed out a year of strong financial performance with solid fourth quarter results as we saw continued strength in electronics end-markets and a return to year-over-year top-line growth in Water & Protection driven by further improvement in water and medical packaging end-markets," said Lori Koch, DuPont Chief Executive Officer.

DowDuPont Investors: Discover news and information relating to Dow & DuPont's merger, corporate governance, stock information, and regulatory filings.

DuPont delivers essential innovations across four businesses—Electronics & Imaging, Transportation & Advanced Polymers, Nutrition & Biosciences, and Safety & Construction. We’re helping to invent a better now, to help humanity thrive.

Jun 1, 2019 · DuPont (NYSE: DD) announced today the final results of its exchange offer, and the final proration factor of 52.5307455 percent, in connection with the previously announced separation of its nutrition and biosciences business (the "NB Business") and merger of Nutrition Biosciences, Inc. ("NB"), a DuPont subsidiary formed to hold the NB Business ...

Jun 1, 2019 · DuPont (NYSE: DD) today announced the commencement of its exchange offer (split-off) whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition Biosciences, Inc. ("NB") common stock.

Jun 1, 2019 · DuPont reaffirms its fourth quarter and full year 2024 financial guidance for net sales, operating EBITDA and adjusted EPS as provided on November 5, 2024 as part of its third quarter earnings release, including the expected continued improved performance in …

Please include your name, address, daytime telephone number, account number, and company name (DuPont de Nemours, Inc.) on all correspondence. Telephone: 1-866-644-4129 1-201-680-6578 (Outside the U.S. and Canada)